14 15 16 17 org/10.1182/blood-2002-10-3317] Svigos JM, Robinson JS, Vigneswarn R. Threatened and ac- tual preterm labor including mode of delivery In: James DK, Weiner CP, Steer PJ, Gonik B, editors. High risk pregnancy: management options. Philadelphia: Elsevier Saunders, 2006: pp. 1304-1320. Ananth CV, Liu S, Joseph KS, Kra- mer MS. Fetal and Infant Health Study Group of the Canadian Peri- natal Surveillance System. A com- parison of Foetal and infant mortali- ty in the United States. Int J Epi- demiol 2009;38:480-9. [18806 278] [doi.org/10.1093/ije/dyn194] Namavar Jahromi B, Salarian L, Shiravani Z. Maternal risk factors and neonatal outcome of the admit- ted patients for preterm spontane- ous uterine contractions. Iran Red Crescent Med J 2011;13:877-83. [22737433] Baraban E, McCoy L, Simon P. Increasing prevalence of gestational diabetes and pregnancy-related hy- pertension in Los Angeles country, California, 1991-2003. Prev Chronic Dis 2008;5:A77. [18558027] 18 Kaplan C, Daffos F, Forestier F, Tertian G, Catherine N, Pons JC, Tchernia G. Fetal platelet counts in thrombocytopenic pregnancy. Lan- cet 1990;336:979-82. [1977013] [doi. org/10.1016/0140-6736(90)924 30-P] 19 Samuels P, Bussel JB, Braitman LE, Tomaski A, Druzin ML, Mennuti MT, Cines DB. Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura. N Eng J Med 1990;323:229-35. [2366833] [doi.org/10.1056/NEJM19 9007263230404] 20 Silver RM, Branch DW, Scott JR. Maternal thrombocytopenia in preg- nancy: Time for a reassessment. Am J Obstet Gynecol 1995;173: 479-82. [7645624] [doi.org/10.10 16/0002-9378(95)90269-4] 21 Levy JA, Murphy LD. Thrombocyto- penia in pregnancy. J Am Board Fam Pract 2002;15:290-7. [12150 462] 22 Payne SD, Resnik R, Moore TR, Hedriana HL, Kelly TF. Maternal characteristics and risk of severe neonatal thrombocytopenia and in- tracranial hemorrhage in pregnan- Pregnancies with thrombocytopenia 23 24 25 cies complicated by autoimmune thrombocytopenia. Am J Obstet Gy- necol 1997;177:149-55. [9240599] [doi.org/10.1016/S0002-9378(97)70 454-X] Stasi R, Provan D. Management of immune thrombocytopenic purpura in adults. Mayo Clin Proc 2004;79: 504-22. [15065616] [doi.org/10.4065/79.4.504] Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grain- ger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ. International consensus report on the interven- tion and management of primary immune thrombocytopenia. Blood 2010;115:168-86. [19846889] [doi.org/10.1182/blood-2009-06-225 565] Cines DB, Bussel JB. How I treat idiopathic thrombocytopenic purpura (ITP). Blood 2005;106:2244-51. [15941913] [doi.org/10.1182/blood- 2004-12-4598] WWW.ircmj.com Vol 14 July 2012 435